Chang‐Yao Hsieh
- Molecular Medicine top 0.2%
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 19
- Endometriosis Research and Treatment 5
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 20
- Pharmaceutical Science top 1%
- Oncology top 5%
-
- Cervical Cancer and HPV Research 20
-
- Angiogenesis and VEGF in Cancer 12
-
- Immunotherapy and Immune Responses 8
-
- Genital Health and Disease 5
-
- Reproductive tract infections research 5
Chang‐Yao Hsieh
86 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Medicine 1.1k
- Reproductive Medicine 443
- Obstetrics and Gynecology 391
- Pharmaceutical Science 265
- Oncology 698
Countries citing papers authored by Chang‐Yao Hsieh
This map shows the geographic impact of Chang‐Yao Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Yao Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Yao Hsieh more than expected).
Fields of papers citing papers by Chang‐Yao Hsieh
This network shows the impact of papers produced by Chang‐Yao Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Yao Hsieh. The network helps show where Chang‐Yao Hsieh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang‐Yao Hsieh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 16 | |
| 2 | 2013 | 8 | |
| 3 | 2011 | 116 | |
| 4 | 2010 | 37 | |
| 5 | 2010 | 47 | |
| 6 | 2009 | 21 | |
| 7 | 2007 | 19 | |
| 8 | 2004 | 30 | |
| 9 | 2004 | 0 | |
| 10 | TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins. | 2001 | 4 |
| 11 | Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines. | 2000 | 40 |
| 12 | 2000 | 94 | |
| 13 | 1998 | 3 | |
| 14 | 1995 | 3 | |
| 15 | 1995 | 14 | |
| 16 | 1995 | 36 | |
| 17 | 1994 | 13 | |
| 18 | 1994 | 7 | |
| 19 | 1992 | 8 | |
| 20 | 1989 | 18 |
About Chang‐Yao Hsieh
Chang‐Yao Hsieh is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Microbiology, Immunology and Epidemiology, having authored 87 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (20 papers), Endometrial and Cervical Cancer Treatments (20 papers), Ovarian cancer diagnosis and treatment (19 papers), Angiogenesis and VEGF in Cancer (12 papers), Immunotherapy and Immune Responses (8 papers), Genital Health and Disease (5 papers), Reproductive tract infections research (5 papers) and Endometriosis Research and Treatment (5 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Reproductive Medicine (443 citations), Obstetrics and Gynecology (391 citations), Pharmaceutical Science (265 citations) and Oncology (698 citations). Chang‐Yao Hsieh has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Ann‐Lii Cheng, Jen‐Kun Lin, Ying‐Jan Wang, Min‐Hsiung Pan, Yuan‐Soon Ho, Liang‐In Lin, Chi‐An Chen, Wen‐Fang Cheng, Chien‐Nan Lee and Lin‐Hung Wei. Their work appears in journals such as Gynecologic Oncology, International Journal of Cancer, Molecular Therapy, Obstetrics and Gynecology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.